Yasmin Khan
Obstetrics & Gynecology · Richardson, TXNPI 1891867297
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,972 of the $3,390 with a category attached, or 87.7%. It is spread thinly across 31 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $849 and has fallen 58.8% since, to $350 in 2025.
Across 194 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$758
- Celularity Inc.$300
- Exeltis, USA Inc.$269
- Avion Pharmaceuticals$189
- Organon$160
- Millicent US Inc$158
- plus $2K from 25 others
What the payments were for
- Speaking & faculty fees$3009%
- Food & beverage$2,97288%
- Education$1193%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 53 | $758 |
| Celularity Inc. | 1 | $300 |
| Exeltis, USA Inc. | 12 | $269 |
| Avion Pharmaceuticals | 14 | $189 |
| Organon | 7 | $160 |
| Millicent US Inc | 8 | $158 |
| Pfizer | 9 | $148 |
| Insulet Corporation | 1 | $139 |
| Sumitomo Pharma America, Inc. | 6 | $133 |
| Ascend Therapeutics US, LLC | 35 | $133 |
| Therapeuticsmd, Inc. | 7 | $115 |
| Galderma Laboratories, L.p. | 1 | $112 |
| Lilly USA, LLC | 7 | $94 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $92 |
| Astellas Pharma US Inc | 1 | $85 |
| Lupin Inc. | 4 | $52 |
| Myovant Sciences Inc. | 2 | $44 |
| Hologic Sales And Service, LLC | 2 | $43 |
| Coopersurgical, Inc. | 3 | $42 |
| Monaghan Medical Corporation | 1 | $36 |
| AMAG Pharmaceuticals, Inc. | 3 | $34 |
| Mayne Pharma Commercial LLC | 1 | $33 |
| Johnson & Johnson | 2 | $32 |
| Sage Therapeutics, LLC | 1 | $31 |
| Duchesnay USA Incorporated | 2 | $28 |
| Northgate Technologies, Inc. | 1 | $26 |
| Merck | 2 | $26 |
| Boston Scientific | 1 | $25 |
| Evofem Biosciences, Inc. | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Zyla Life Sciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$139
How this compares
$3,390 in reported general payments places this provider in the 75th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 25 | $1,421 |
| Alendronate Sodium | 16 | $63 |
| Fluconazole | 13 | $45 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Richardson
- William SalterRichardson$48K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.